You are at the center of everything we do at Seattle Cancer Care Alliance (SCCA). Here, we surround you with a team of specialists who work together closely to provide evidence-based, comprehensive and compassionate hematologic care.
We guide you every step of the way, combining our clinical expertise in treating adults who have sickle cell disease with a commitment to meet your unique needs.
Request an appointment
Why choose SCCA for sickle cell disease treatment?
Experienced sickle cell specialists
Many health care providers in the community have limited experience treating adults with sickle cell disease. More than half of doctors say they have no patients with this condition and they are uncomfortable managing the acute and chronic pain associated with the disease.1 At SCCA, you receive state-of-the-art care from some of the world’s leading hematologists, who have the training and experience to meet your needs.
Comprehensive sickle cell treatment
Our doctors provide the full spectrum of treatments sickle cell disease may require. Based on your unique situation, this may include hydroxyurea, red blood cell transfusions, pain medications and careful consideration of bone marrow transplant. Your care providers work with you to address your symptoms, maintain your health and prevent or manage disease-related complications.
Bone marrow transplant for sickle cell disease
The Fred Hutch Bone Marrow Transplant Program at SCCA consistently achieves higher-than-expected transplant survival rates. We pioneered bone marrow transplants and have performed more than any other institution in the world. For sickle cell disease, a bone marrow transplant currently provides the only hope for a cure.
Sickle cell research
To give you access to the most innovative care, SCCA unites the leading researchers and hematologists of Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Children’s. We conduct clinical studies on bone marrow transplantation for sickle cell and are working to open new studies here so you can access other promising options that are not available everywhere.
NCI comprehensive cancer center
We are a comprehensive cancer center, a designation from the National Cancer Institute that reflects our scientific leadership and the depth and breadth of our research to prevent, diagnose and treat cancer. Our doctors and scientists bring the same commitment to nonmalignant blood disorders, like sickle cell disease.
1. ASH Sickle Cell Disease Initiative Fund, American Society of Hematology.